Nobel-winning virologist starts hepatitis C vaccine programme in Hong Kong
โฎ BeforeNo hepatitis C vaccine exists.
โ
NowA programme to develop one has launched at Baptist University in Hong Kong.
In short
- Sir Michael Houghton won the 2020 Nobel Prize for co-discovering the hepatitis C virus.
- He joined Baptist University after more than four decades in North America.
- The programme draws on Hong Kong research funding, Chinese virus strains and mainland drug maker partnerships.
Why it's good news
Hepatitis C is a liver virus, and no vaccine against it exists today. The programme is at launch, so no vaccine is in trials yet. Its links to local funding, virus samples and drug makers give it resources a new team would otherwise lack.
Advertisement
From South China Morning Post
A British Nobel-winning virologist has launched a programme to develop the worldโs first hepatitis C vaccine after joining a university in Hong Kong, tapping the cityโs research funding, access to Chinese strains of the virus and partnerships with mainland drug makers. Sir Michael Houghton, who won the 2020 Nobel Prize in Physiology or Medicine for the co-discovery of the hepatitis C virus, said he joined Baptist University after more than four decades in North America, as the United States and...
Ask this story
More like this
Advertisement